source
- FDA faces Roche blackmail claim, launches mifepristone safety study and reviews voucher program pause requestRoche has publicly accused the United States of blackmail in a dispute that surfaced in recent FDA discussions. The company’s allegation adds tension to ongoing regulatory dialogues. The Food and…
- Uli Stilz joins Flagship while Revolution Medicines adds Alex Hoffman as commercial leadOn June 5, 2026, biotech veteran Uli Stilz announced his new position at Flagship, marking a notable personnel shift in the industry. Stilz has spent much of the year traveling internationally, in…